The Ethics of Prescribing and Access in Atopic Dermatitis: Can We Separate Them? Therapeutic innovation in atopic dermatitis (AD) has advanced rapidly. Biologics and targeted therapies have transformed the outlook for patients with severe disease. Yet a central ethical tension is emerging: what is the value of prescribing the best treatment if patients cannot access […]
Read More
Prof Kin Fon LEONG from Malaysia kindly shares his book with the ISAD community — many thanks! Two educative booklets from Malaysia Fore word Dr Yong Kwang TAY, FRCPSingapore
Read More
A New Chapter in International Partnership We are pleased to announce the signature of a Memorandum of Understanding (MoU) between the International Society of Atopic Dermatitis (ISAD) and the European Academy of Allergy and Clinical Immunology (EAACI), formalizing a strengthened collaboration between our two societies. This partnership reflects our shared commitment to advancing excellence in patient care, education, and research […]
Read More
AI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas
Read More
You are invited! DEADLINE FRIDAY 6 FEBRUARY 2026 As a board- certified dermatologist practicing in an African country, you are invited to participate in a modified e-Delphi consensus process to support the development of the African Clinical Practice Guidelines for the Diagnosis and Management of Atopic Dermatitis (Eczema), led by the African Society of Dermatology […]
Read More
What JACI’s 2025 Review Tells Us In 2024, following the fourth Global Allergy Forum in Davos, the journal Allergy published the 4th Davos Declaration, identifying atopic dermatitis (AD) as the prototype of epithelial barrier–driven chronic inflammatory diseases and a gateway to other allergic conditions (DOI: 10.1111/all.16247). In 2025, the Journal of Allergy and Clinical Immunology […]
Read MoreAI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas
Read More
Aligning Measurement with Patient Experience At the ISAD–WHO closed workshop held in Melbourne in October 2025, international experts and patient representatives explored how a Treat-to-Target (T2T) strategy could be meaningfully adapted to atopic dermatitis (AD). The meeting brought together dermatologists, pediatric dermatologists, allergists, rheumatologists, pulmonologists, pharmacists, global health experts, and patient advocates from Europe, Asia, […]
Read More
Motto: Science and Empathy in Atopic Dermatitis 17-19 October 2026, Beijing, China + New in 2026 for Early-Career Pros: All you need to know about AD Dear ISADers, We are proud and excited to welcome you in Beijing, China, to the 16th Georg RAJKA International Symposium on Atopic Dermatitis (ISAD), in 2026. Its motto “Science […]
Read More
One Th2 Response, Two Outcomes: Itch Versus Inflammation?➜ DOI: 10.1111/exd.70171This research letter suggests that pruritus and inflammation may be driven by partially distinct Th2 programs. In mouse models of dermatitis, IL-31 is mainly produced by a specific subset of T cells, whereas IL-5 and IL-13 are largely derived from ILC2s. This cellular dissociation offers a plausible [...] Read More